{
  "retracted": false,
  "timestamp": 1536710400000,
  "updates": [
    {
      "timestamp": 1585016545582,
      "identifier": {
        "doi": "10.1038/s41598-018-31455-w"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1038/s41598-018-28449-z"
  },
  "publisher": "Springer Science and Business Media LLC",
  "title": "Author Correction: Post-treatment with PT302, a long-acting Exendin-4 sustained release formulation, reduces dopaminergic neurodegeneration in a 6-Hydroxydopamine rat model of Parkinsonâ€™s disease"
}
